Literature DB >> 1853620

The influence of surgery on the risk of death in patients with primary hyperparathyroidism.

G Hedbäck1, A Odén, L E Tisell.   

Abstract

The previous finding of an increased risk of premature death in a consecutive series of 896 patients operated on for primary hyperparathyroidism between 1953 and 1982 [1] raised the question of the role that surgery plays in relation to the risk of death. In the present study, undertaken to examine that issue, 3 factors--age, calendar year of surgery, and time passed after surgery--have been found to be significantly related to the risk of death (p less than 0.001), each factor contributing independently. A correlation was found between a late calendar year of surgery and a low degree of hyperparathyroidism as evaluated by serum calcium and creatinine levels. There was an increased risk of premature death in all age groups. The risk was less among patients operated on in later years. The observed normalization of the increased risk of death with time after surgery also took place sooner in patients operated on in later years. Our findings of improved survival following surgical intervention contrasts favorably with the findings of others in studies of subjects with untreated mild hyperparathyroidism. We have also found that preoperative serum calcium levels affect the risk of death, and that there is an additional factor related to the calendar year of surgery affecting the risk of death. Circumstantial evidence indicates that the duration of hyperparathyroidism contributes to this factor. Our results also show that early surgery decreases the risk of premature death in mild cases of the disease.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1853620     DOI: 10.1007/bf01658740

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  25 in total

1.  Psychiatric morbidity in primary hyperparathyroidism.

Authors:  C Joborn; J Hetta; H Johansson; J Rastad; H Agren; G Akerström; S Ljunghall
Journal:  World J Surg       Date:  1988-08       Impact factor: 3.352

2.  Myxofibrosarcoma. A malignant soft tissue tumor of fibroblastic-histiocytic origin. A clinicopathologic and prognostic study of 110 cases using multivariate analysis.

Authors:  C Merck; L Angervall; L G Kindblom; A Odén
Journal:  Acta Pathol Microbiol Immunol Scand Suppl       Date:  1983

3.  Does mild, asymptomatic hyperparathyroidism require surgery?

Authors:  F L Coe; M J Favus
Journal:  N Engl J Med       Date:  1980-01-24       Impact factor: 91.245

4.  Asymptomatic hyperparathyroidism: an assessment of operative intervention.

Authors:  J J Graham; P E Harding; L L Hoare; D W Thomas; P H Wise
Journal:  Br J Surg       Date:  1980-02       Impact factor: 6.939

5.  Primary hyperparathyroidism. A review of the long-term surgical and nonsurgical morbidities as a basis for a rational approach to treatment.

Authors:  F W Lafferty; C A Hubay
Journal:  Arch Intern Med       Date:  1989-04

6.  Is parathyroidectomy of benefit in primary hyperparathyroidism?

Authors:  S Posen; P Clifton-Bligh; T S Reeve; C Wagstaffe; M Wilkinson
Journal:  Q J Med       Date:  1985-03

7.  Improvement of muscle strength after treatment for hyperparathyroidism.

Authors:  I Hedman; G Grimby; L E Tisell
Journal:  Acta Chir Scand       Date:  1984

Review 8.  The medical management of primary hyperparathyroidism.

Authors:  J P Bilezikian
Journal:  Ann Intern Med       Date:  1982-02       Impact factor: 25.391

9.  Survival and renal function in untreated hypercalcaemia. Population-based cohort study with 14 years of follow-up.

Authors:  M Palmer; H O Adami; R Bergström; S Jakobsson; G Akerström; S Ljunghall
Journal:  Lancet       Date:  1987-01-10       Impact factor: 79.321

10.  Bone mineral changes in primary hyperparathyroidism.

Authors:  M L Richardson; R S Pozzi-Mucelli; A S Kanter; F O Kolb; B Ettinger; H K Genant
Journal:  Skeletal Radiol       Date:  1986       Impact factor: 2.199

View more
  25 in total

1.  Effect of parathyroidectomy on subclinical cardiovascular disease in mild primary hyperparathyroidism.

Authors:  M D Walker; T Rundek; S Homma; M DiTullio; S Iwata; J A Lee; J Choi; R Liu; C Zhang; D J McMahon; R L Sacco; S J Silverberg
Journal:  Eur J Endocrinol       Date:  2012-06-01       Impact factor: 6.664

2.  Population based case-control study of sick leave in postmenopausal women before diagnosis of hyperparathyroidism.

Authors:  E Lundgren; E Szabo; S Ljunghall; R Bergström; L Holmberg; J Rastad
Journal:  BMJ       Date:  1998-09-26

3.  Aortic valve calcification in mild primary hyperparathyroidism.

Authors:  Shinichi Iwata; Marcella Donovan Walker; Marco R Di Tullio; Eiichi Hyodo; Zhezhen Jin; Rui Liu; Ralph L Sacco; Shunichi Homma; Shonni J Silverberg
Journal:  J Clin Endocrinol Metab       Date:  2011-10-26       Impact factor: 5.958

Review 4.  Primary hyperparathyroidism, cognition, and health-related quality of life.

Authors:  Laura H Coker; Kashemi Rorie; Larry Cantley; Kimberly Kirkland; David Stump; Nicole Burbank; Terry Tembreull; Jeff Williamson; Nancy Perrier
Journal:  Ann Surg       Date:  2005-11       Impact factor: 12.969

5.  Cardiac structure and diastolic function in mild primary hyperparathyroidism.

Authors:  M D Walker; J B Fleischer; M R Di Tullio; S Homma; T Rundek; E M Stein; C Zhang; T Taggart; D J McMahon; S J Silverberg
Journal:  J Clin Endocrinol Metab       Date:  2010-03-12       Impact factor: 5.958

Review 6.  Cardiovascular aspects of primary hyperparathyroidism.

Authors:  M D Walker; S J Silverberg
Journal:  J Endocrinol Invest       Date:  2008-10       Impact factor: 4.256

Review 7.  Nontraditional manifestations of primary hyperparathyroidism.

Authors:  Marcella Donovan Walker; Mishaela Rubin; Shonni J Silverberg
Journal:  J Clin Densitom       Date:  2013 Jan-Mar       Impact factor: 2.617

8.  Carotid vascular abnormalities in primary hyperparathyroidism.

Authors:  M D Walker; J Fleischer; T Rundek; D J McMahon; S Homma; R Sacco; S J Silverberg
Journal:  J Clin Endocrinol Metab       Date:  2009-09-15       Impact factor: 5.958

9.  Normocalcemia and persistent elevated serum concentrations of 1-84 parathyroid hormone after operation for sporadic parathyroid adenoma: evidence of increased morbidity from cardiovascular disease.

Authors:  Henrik Vestergaard; Lars ØStergaard Kristensen
Journal:  World J Surg       Date:  2002-03-01       Impact factor: 3.352

10.  Primary hyperparathyroidism and the heart: cardiac abnormalities correlated to clinical and biochemical data.

Authors:  F Längle; C Abela; J Koller-Strametz; M Mittelböck; J Bergler-Klein; T Stefenelli; W Woloszczuk; B Niederle
Journal:  World J Surg       Date:  1994 Jul-Aug       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.